The role of Pharmacy Benefit Managers, the PBMs, in the US healthcare system has been detailed on this blog several times. And each time, it seems, the public is able to better understand how detrimental some of theses practices are to our healthcare system. A few days ago, a blog post from Lexology entitled PBMs and Drug Pricing: Congress and Major U.S. Employers Start to Unravel the Hidden Pricing Mechanisms of PBMs describes many of these practices.
The overall of awareness of PBM tactics increasing rapidly. This is a good thing for healthcare in the United States, because these tactics have only emphasized the drug product while completely ignoring patient care. Increased transparency will hopefully put pharmacy back into the pharmacy benefit.
